Skip to content

Clinical trials

Nephrolithiasis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nephrolithiasis Country / region: Canada Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20142
20151
20171
20182
20203
20211
20222
20233
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Not yet recruiting3
Unknown status3
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Calcilytix Therapeutics, Inc., a BridgeBio company2
Centre hospitalier de l'Université de Montréal (CHUM)2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2
University of British Columbia2
Adva-Tec1
Children's Hospital of Philadelphia1
Clinical Urology and Epidemiology Working Group1
Mayo Clinic1
Nova Scotia Health Authority1
Sault Area Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nephrolithiasis21
Kidney Calculi11
Urolithiasis3
Calcium Metabolism Disorders2
Hypercalciuria2
Hypocalcemia2
Hypoparathyroidism2
Metabolic Diseases2
Muscular Diseases2
Musculoskeletal Abnormalities2

Trials

Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.